Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
SPECIAL ANNOUNCEMENT
2016 Photonics Buyers' Guide Clearance! – Use Coupon Code FC16 to save 60%!
share
Email Facebook Twitter Google+ LinkedIn Comments

Fox Chase Cancer Center

BioPhotonics
Aug 2008
Fox Chase Cancer Center of Philadelphia and VisEn Medical Inc. of Woburn, Mass., have partnered to advance the Phase I clinical trials of the company’s “smart” fluorescence-activatable imaging agents, which they hope will enable physicians to identify and characterize early-stage disease in oncology patients. The trials initially will focus on ovarian cancer and are scheduled to begin in 2009.


Comments
Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2016 Photonics Media
x Subscribe to BioPhotonics magazine - FREE!